Biallelic loss-of-function mutations in dedicator of cytokinesis 8 (DOCK8) cause a combined immunodeficiency also known as autosomal recessive hyper-IgE syndrome (AR-HIES). 1, 2 Affected patients typically present with recurrent Staphylococcus aureus skin infections, recurrent and severe cutaneous viral infections (herpes simplex virus [HSV] , human papilloma virus [HPV] , and Molluscum contagiosum virus), increased serum IgE levels, lymphopenia, eosinophilia, and an increased risk of malignancy.
1-3 DOCK8-deficient patients also exhibit impaired humoral immune responses against protein and polysaccharide antigens after natural infection or vaccination. Strikingly, DOCK8 deficiency predisposes most affected patients to asthma and severe allergies against food and environmental antigens. [1] [2] [3] [4] [5] However, the mechanisms underlying severe allergy are currently unknown.
DOCK8 functions as a guanine nucleotide exchange factor to activate Rho-family GTPases, such as CDC42, which mediate events, including cell activation, division, survival, differentiation, adhesion, and migration. [6] [7] [8] Despite this, it is not immediately clear how DOCK8 mutations result in the devastating immune abnormalities characteristic of patients with AR-HIES. However, because DOCK8 is predominantly expressed by hematopoietic cells, it is likely to play critical lymphocyte-intrinsic roles in cellular and humoral immune responses against infectious diseases. Consistent with this, allogeneic hematopoietic stem cell transplantation overcomes recurrent cutaneous viral infections and eczematous rash and reduces IgE levels and eosinophilia. [9] [10] [11] [12] [13] [14] In regard to food allergies in patients with DOCK8 deficiency, some reports have documented improvement after hematopoietic stem cell transplantation, 10, 11, 14 whereas others reported amelioration of symptoms 13 or no change. 9, 15 Ex vivo and in vitro analyses of lymphocytes from DOCK8-deficient patients have shed some light on disease pathogenesis. For instance, DOCK8-deficient patients have normal to increased numbers of total B cells but decreased circulating memory (CD27 1 ) B cells. 5, 16 Functionally, compared with normal B cells, DOCK8-deficient B cells exhibit poor responses to the Toll-like receptor 9 ligand CpG, whereas CD40-mediated responses were largely intact. 5 In B cells DOCK8 acts as an adaptor protein connecting the Toll-like receptor 9-myeloid differentiation primary response gene-88 pathway to signal transducer and activator of transcription (STAT) 3 signaling, which is required for B-cell proliferation and differentiation, as evidenced by defective function of STAT3-deficient human B cells in vivo and in vitro. [17] [18] [19] [20] These defects underlie poor humoral immunity in patients with DOCK8 deficiency. Paradoxically, an increase in autoantibodies directed against nuclear, cytoplasmic, and extracellular matrix antigens has been detected in DOCK8-deficient patients, possibly because of decreased regulatory T (Treg) cell numbers in these patients. 21 Our previous study of T cells in DOCK8-deficient patients revealed a severe reduction in naive, central memory (CD45RA terminally differentiated (ie, ''exhausted'') effector memory cells. 22 Strikingly, central and effector memory CD8 1 T cells from DOCK8-deficient subjects displayed phenotypic features of exhaustion, with increased expression of CD57, 2B4, and CD95 and accelerated loss of CD28 and CD127 (IL-7 receptor a). 22 Furthermore, DOCK8-deficient naive and memory CD8
1 T cells did not proliferate in vitro in response to T-cell receptor (TCR) stimulation. 22 More recently, DOCK8-deficient CD8 1 T cells were reported to undergo ''cytothripsis,'' a form of cell death associated with defects in morphology and trafficking that prevented the generation of long-lived resident memory CD8 1 T cells in the skin and subsequently impaired immune responses to herpes virus infection at this site. 23 Taken together, these defects in CD8 1 T cells provide a plausible explanation for viral susceptibility in DOCK8-deficient patients. DOCK8-deficient patients also have defects in the development of invariant natural killer (NKT) cells and NK cell function, 24, 25 which might contribute to increased susceptibility to viral infections and malignancies.
In contrast to these established defects in B cells, Treg cells, CD8
1 T cells, NK cells, and NKT cells, much less is known about the consequences of DOCK8 mutations on other human CD4 1 T helper cells. Although it has been reported that the frequencies of naive and memory CD4
1 T cells in DOCK8-deficient patients are normal, DOCK8-deficient naive and memory CD4 1 T cells do have a defect in TCR-induced proliferation, although less severe than that seen in DOCK8-deficient CD8 1 T cells. 22 Consequently, this deficit is unlikely to cause clinical features, such as atopic disease (dermatitis and severe food allergies) and increased IgE levels in patients with DOCK8 deficiency. For this reason, we have undertaken a detailed analysis of the CD4 1 T-cell compartment in DOCK8-deficient patients. We found that DOCK8-deficient memory CD4
1 T cells have a bias toward T H 2 cytokine expression (ie, IL-4, IL-5, and IL-13) and concomitant defective production of T H 1 (IFN-g) and T H 17 (IL-17A, IL-17F, and IL-22) cytokines. Furthermore, the T H 2 cytokine bias and impaired T H 17 immunity in the absence of DOCK8 were T cell intrinsic and independent of defects in proliferation. This intrinsic T H 2 bias of DOCK8-deficient CD4 1 T cells might underlie atopic disease and hyper-IgE displayed by DOCK8-deficient patients. Additionally, impaired T H 1 and T H 17 responses likely account for impaired viral immunity and fungal infections, such as chronic mucocutaneous candidiasis (CMC), respectively, in DOCK8-deficient patients. 
METHODS

Human samples
PBMCs, plasma, or both were isolated from healthy donors (Australian Red Cross) and patients with DOCK8 deficiency (Table I ). The genotype of some of these patients has been previously reported.
1,2,15,22,24 All studies were approved by institutional human research ethics committees, and written informed consent was obtained from patients.
Antibodies and reagents
Alexa Fluor 488-anti-GATA-3, Alexa Fluor 647-anti-CXCR5, allophycocyanin (APC)-Cy7-anti-CD4, BUV395-anti-IFN-g, BV711-anti-CD69, BV711-anti-IL-2, phycoerythrin (PE)-anti-CCR6, PE-anti-CD95, Pe-Cy7-anti-CD25, anti-mouse IgG 1 , PerCpCy5.5-anti-CD127, and anti-Tbox transcription factor (T-bet) were from Becton Dickinson (Mountain View, Calif). Alexa Fluor 488-anti-IL-10, APC-anti-inducible costimulator (ICOS), eFluor660-anti-IL-21, fluorescein isothiocyanate-anti-CD45RA, PE-IL-22, Pe-Cy7-anti-IL-4, and mouse IgG 1 were from eBioscience (San Diego, Calif). APC-Cy7-anti-IL-17A, BV421-anti-CXCR3, and BV605-anti-TNF-a were from BioLegend (San Diego, Calif). Fluorescein isothiocyanate-anti-CCR7 and recombinant human IL-12 were from R&D Systems (Minneapolis, Minn). Anti-DOCK8 mAb was from Santa Cruz Biotechnology (Dallas, Tex). Recombinant human TGF-b, IL-1b, IL-6, IL-21, and IL-23 were from PeproTech (Rocky Hills, NJ). Prostaglandin E 2 , phorbol 12-myristate 13-acetate (PMA), calcium ionophore (ionomycin), Brefeldin A, and saponin were purchased from Sigma-Aldrich (St Louis, Mo). Recombinant human IL-4 was provided by Dr Rene de Waal Malefyt (DNAX Research Institute, Palo Alto, Calif). T-cell activation and expansion (TAE) beads (anti-CD2/CD3/CD28) were purchased from Miltenyi Biotec (Bergisch Gladbach, Germany), and carboxyfluorescein succinimidyl ester (CFSE) was purchased from Invitrogen (Carlsbad, Calif).
CD4
1 T-cell phenotyping
To identify naive, central memory T (T CM ) cell, and effector memory T (T EM ) cell CD4
1 populations, PBMCs were incubated with mAbs to CD4, CCR7, and CD45RA, and the frequency of CD4
(T EM ) populations were determined by using flow cytometry. To identify CD4 1 T-cell populations, PBMCs were incubated with mAbs to CD4, CD25, CD127, CXCR5, CD45RA, CCR6, and CXCR3, and the frequency of Treg 22 were isolated by sorting on a FACSAria (Becton Dickinson; >98% purity) and cultured with TAE beads (anti-CD2/CD3/CD28) in 96-well, round-bottomed plates. After 5 days, supernatants were harvested, and production of IL-2, IL-4, IL-5, IL-6, IL-10, IL-13, IL-17A, IL-17F, IFN-g, and TNF-a was determined by using the cytometric bead array (Becton Dickinson). For cytokine expression, activated T cells were restimulated with PMA (100 ng/mL) and ionomycin (750 ng/mL) for 6 hours, with Brefeldin A (10 mg/mL) added after 2 hours. Cells were then fixed with formaldehyde, and expression of IFN-g, IL-4, IL-17A, IL-22, IL-21, IL-10, TNF-a, and IL-2 was detected by means of intracellular staining. 20, [26] [27] [28] Analysis of transcription factor expression by CD4
1
T cells
Expression of T-bet and GATA-3 protein was assessed by means of intracellular staining with a Fix/Perm kit from eBioscience. Expression of RAR-related orphan receptor C (RORC) was determined by using quantitative PCR. 28 
Analysis of DOCK8 expression
PBMCs were fixed with formaldehyde and stained with an unconjugated DOCK8 or an isotype control IgG 1 mAb to determine intracellular DOCK8 expression. PE-rat anti-mouse IgG 1 was then used with saponin as the permeabilizing agent. 29 
Analysis of CD4
1 T-cell proliferation
Naive and memory CD4 1 T cells were isolated by means of sorting and then labeled with CFSE. Their proliferation status was determined by assessing dilution of CFSE after 5 days of in vitro culture.
27,28 
ImmunoCAP assay
Plasma from healthy donors and DOCK8-deficient patients was analyzed for allergen-specific IgE antibodies by the Sydney South West Pathology Service (Royal Prince Alfred Hospital, Sydney, Australia) using the Phadia 250 ImmunoCAP platform (Thermo Scientific, Waltham, Mass). IgE levels specific for a staple food mix (FX5; egg white, milk, codfish, wheat, peanut, and soybean) or house dust mite mix was determined.
Statistical analysis
Significant differences were determined by using either the Student t test, multiple t tests, or 1-or 2-way ANOVA (Prism software; GraphPad Software, La Jolla, Calif).
RESULTS
Effects of DOCK8 deficiency on the generation of effector CD4
1 T-cell subsets in vivo
As an initial step in investigating CD4 1 T-cell function in the absence of DOCK8, we assessed the CD4 1 T-cell compartment to determine whether the generation and differentiation of CD4 1 T cells was affected by DOCK8 deficiency and whether this could contribute to the combined immunodeficiency typical of these subjects. We previously investigated the peripheral Tcell compartment in a small cohort (n 5 6) of DOCK8-deficient patients. 22 We have now increased our cohort to comprise 18 subjects from 15 unrelated families and have extended our analysis to include additional surface markers to further distinguish different subsets within the CD4 1 T-cell population (Fig 1) . DOCK8 expression in lymphocytes and monocytes from a representative healthy control subject, 1 unaffected sibling, and 4 DOCK8-deficient patients is depicted in Fig E1 in this article' s Online Repository at www.jacionline.org. Analysis of this larger cohort of DOCK8-deficient patients confirmed a statistically significant reduction in numbers of CD4 1 T cells compared with those seen in healthy donors (Fig 1, A) . Naive, T CM , and T EM CD4 1 T cells can be resolved according to the differential expression of CD45RA and CCR7 (Fig 1, B) . 31 This analysis revealed that the naive and T CM compartments in DOCK8-deficient patients are comparable with those of healthy subjects but that T EM CD4
1 T-cell numbers were significantly increased in DOCK8-deficient patients (Fig 1, C) . Hence despite the reduction in total CD4
1 T-cell numbers, DOCK8-deficient CD4 1 T cells differentiate normally into naive and T CM cells; this is accompanied by a mild increase in T EM cell numbers.
Using a recently described gating strategy, 20, 32 we next examined the CD4 1 T-cell compartment for additional effector subsets: CD25 hi CD127 lo Treg (Fig 1, D and G 
T H 2 (Fig 1, F and G) , and CD45RA
2
CXCR5
2 CXCR3
2
CCR6
1 T H 17 (Fig 1, F and G) cells. DOCK8-deficient patients had an increased frequency of Treg cells (Fig 1, D and G ) but decreased frequency of T H 17 cells (Fig 1, F and G) , whereas frequencies of T FH , T H 1, and T H 2 cells according to this phenotypic delineation in patients were similar to those of healthy donors (Fig 1, D-G) . Thus there is a selective paucity of T H 17 cells due to DOCK8 mutations.
Assessment of expression of additional surface markers associated with CD4
1 T-cell differentiation indicated that the naive, T CM , and T EM CD4
1 T-cell populations from DOCK8-deficient patients had undergone greater activation and terminal differentiation than corresponding CD4
1 T-cell subsets isolated from healthy donors (Fig 1, H-M) . Specifically, loss of expression of CD27 (Fig 1, H) , CD28 (Fig 1, I) , and CD127 (Fig 1, J) and acquisition of CD57 (Fig 1, K) , CD95 (Fig 1, L) , and programmed cell death protein 1 (PD-1; Fig 1, M) by CD4 1 T CM and T EM cells was exaggerated for DOCK8-deficient patients compared with that seen in control subjects. Collectively, DOCK8 deficiency compromises the generation of T H 17 cells and results in the premature terminal differentiation of memory cells, such that they acquire a senescent/exhausted phenotype.
DOCK8-deficient memory CD4
1 T cells are biased toward T H 2 cytokines
Given the decrease in numbers of CCR6
1
CXCR3
2 cells, which are enriched for T H 17 cytokine-producing cells in healthy donors, 20, [34] [35] [36] in DOCK8-deficient patients, we investigated cytokine expression by naive and memory CD4 1 T cells (Fig 2) . Naive and total memory (CD45RA
T cells were sort purified from normal donors and DOCK8-deficient patients and then cultured with TAE beads conjugated to anti-CD2/CD3/CD28 mAbs for 5 days. After this time, cells were restimulated with PMA/ionomycin, and intracellular expression of IFN-g, IL-4, IL-17A, IL-22, IL-21, IL-10, TNF-a, and IL-2 was determined (Fig 2) . Apart from IL-2 (Fig 2, A) and TNF-a (Fig 2, B) , which are expressed by 40% to 80% of normal naive cells, only a small proportion of naive cells (ie, <5%) expressed any of the other cytokines examined. DOCK8-deficient naive CD4
1 T cells expressed comparable levels of IL-2 (Fig 2, A) and TNF-a (Fig 2, B) to those of normal naive CD4
1 T cells. However, analysis of the memory CD4 1 T-cell compartment in DOCK8-deficient patients revealed marked perturbations in differentiation in vivo. A significantly greater proportion of DOCK8-deficient memory CD4 1 T cells expressed IL-4 compared with normal memory CD4 1 T cells (Fig 2, C) , suggesting a skewing to the T H 2 effector lineage. Examination of mean fluorescence intensity of IL-4 1 cells in DOCK8-deficient and normal memory CD4 1 T cells revealed no significant differences (data not shown), suggesting there is an increase in the frequency of IL-4-expressing cells in the DOCK8-deficient memory CD4
1 T-cell compartment but that a comparable amount of IL-4 is produced per cell. The increase in numbers of IL-4 1 cells in DOCK8-deficient memory CD4
1 T cells was accompanied by significant reductions in expression of the T H 1 cytokines IFN-g (Fig 2, D) and TNF-a (Fig 2, B) , the T H 17 cytokines IL-17A (Fig 2, E) and IL-22 (Fig 2, F) , and the T FH cytokine IL-21 (Fig 2, G) . Expression of IL-10 (Fig 2,  H) and IL-2 (Fig 2, A) by memory CD4 1 T cells was unaffected by DOCK8 deficiency.
The T H 2 skewing by DOCK8-deficient memory CD4 1 T cells was also assessed by measuring cytokine secretion during the 5-day culture (Fig 3) . This indicated concordance between the expression and secretion of cytokines when assessed by using intracellular staining and flow cytometry or the cytometric bead array, respectively. Analysis of an extended panel of cytokines showed that DOCK8-deficient memory T cells secreted not only more IL-4 than normal memory CD4 1 T cells but also more of the T H 2 cytokines IL-5 and IL-13 (Fig 3, A-C ) and less of the T H 1 (IFN-g and TNF-a; Fig 3, D and E) and T H 17 (IL-17A and IL-17F ; Fig 3, F and G) cytokines. Production of IL-6 (Fig 3, H) was also significantly reduced. There were trends for less production of IL-10 and IL-2 by DOCK8-deficient memory CD4
1 T cells; however, these reduced values were not significant (Fig 3, I and J) . Production of TNF-a and IL-2 by DOCK8-deficient naive CD4
1 T cells was normal (Fig 3, E  and J) . Taken together, memory CD4
1 T cells from DOCK8-deficient patients display a T H 2 bias, primarily expressing IL-4, IL-5, and IL-13 and notably lower levels of cytokines characteristic of other T helper subsets.
T H 2 cytokine bias by DOCK8-deficient memory CD4 1 T cells is independent of defects in cell proliferation Previous work showed that lymphocyte differentiation, such as immunoglobulin class-switching and antibody secretion by naive and DOCK8-deficient patients (open symbols; n 5 18) were enumerated based on expression of CD45RA and CCR7. D-G, PBMCs were labeled with mAbs against CD4, CD45RA, CD25, CD127, CXCR5, CXCR3, and CCR6. Fig 1, D (open symbols) were identified and assessed for expression of CD27 (Fig 1, H) , CD28 (Fig 1, I ), CD127 (Fig 1,  J) , CD57 (Fig 1, K) , CD95 (Fig 1, L) , and PD-1 (Fig 1, M) . Each point corresponds to the mean 6 SEM percentage of cells expressing the indicated surface receptor or the mean fluorescence intensity (MFI) of expression (n 5 4-12 healthy donors or DOCK8-deficient patients). Statistics were performed with Prism software by using the t test. *P < .05 and **P < .01. 
hours. Intracellular expression of IL-2 (A), TNF-a (B), IL-4 (C), IFN-g (D), IL-17A (E), IL-22 (F), IL-21 (G)
, and IL-10 (H) was determined by using saponin as the permeabilizing agent, followed by flow cytometric analysis. Data represent means 6 SEMs of 8 healthy donors or 8 DOCK8-deficient patients. Statistics were performed with Prism software by using 1-way ANOVA. *P < .05, **P < .01, ***P < .005, and ****P < .001. IL-13 independently of differences in cell proliferation. Naive and memory CD4 1 T cells were sorted from healthy donors and DOCK8-deficient patients and cultured with TAE beads for 5 days. A-J, After this time, culture supernatants were examined for secretion of IL-4 (Fig 3, A) , IL-5 (Fig 3, B) , IL-13 (Fig 3, C) , IFN-g (Fig 3, D) , TNF (Fig 3, E) , IL-17A (Fig 3, F) , IL-17F (Fig 3, G) , IL-6 (Fig 3, H) , IL-10 (Fig 3, I) , and IL-2 (Fig 3, J) by using a custom-designed cytometric bead array (BD Biosciences). Data represent means 6 SEMs of experiments by using cells from 9 healthy donors or DOCK8-deficient patients. Statistics were performed with Prism software by using 1-way ANOVA. K and L, Naive (Fig 3, K) and memory (Fig 3, L ) CD4 1 T cells were isolated from healthy donors (n 5 4) and DOCK8-deficient patients (n 5 4), labeled with CFSE, and cultured with TAE beads for 5 days. After this time, the frequency of cells in each division was determined by means of dilution of CFSE. M, Sorted naive and memory CD4 1 cells were immediately restimulated with PMA/ionomycin for 6 hours in the presence of Brefeldin A and IL-4 expression determined by using intracellular staining and flow cytometry. N and O, Naive and memory CD4 1 T cells were labeled with CFSE and cultured with TAE beads for 5 days, and the proportion of cells expressing IFN-g (Fig 3, L) or IL-4 (Fig 3, M) in each division interval was determined by means of dilution of CFSE. Data represent means 6 SEMs of 2 to 4 healthy donors and DOCK8-deficient patients. *P < .05 and **P < .01.
B cells and cytokine production and cell-surface phenotype expression by naive T cells, is regulated by cell division. 27, [37] [38] [39] DOCK8-deficient naive (Fig 3, K) and memory (Fig 3, L ) CD4 1 T cells were found to have impaired cell division in vitro, which is consistent with previous findings. 22 Thus it was possible that the perturbed cytokine profile reflected reduced proliferation by DOCK8-deficient memory CD4
1 T cells. However, the T H 2 bias of DOCK8-deficient memory CD4
1 T cells was not due to a proliferative defect, as evidenced by 2 important and related findings.
First, when memory cells were isolated and restimulated immediately for analysis of cytokine expression, the preferential production of IL-4 by DOCK8-deficient over normal memory CD4
1 T cells was still observed in the absence of cell proliferation (Fig 3, M) . Similarly, the poor production of T H 1 and T H 17 cytokines by DOCK8-deficient memory CD4 1 T cells did not result from impaired proliferation because reductions in expression of IFN-g (normal, 17.7%; DOCK8, 6.9%) and IL-22 (normal, 3.7%; DOCK8, 1.8%), respectively, were also observed when assessed under these ex vivo stimulatory conditions.
Second, analysis of cells that had undergone different rounds of division in vitro revealed that the decrease in IFN-g (Fig 3, N) and increase in IL-4 (Fig 3, O) levels displayed by DOCK8-deficient versus normal memory CD4 1 T cells was evident for all division intervals examined. Thus the preference of DOCK8-deficient memory CD4
1 T cells to produce T H 2, but not T H 1, cytokines is independent of any proliferative defects in these cells.
Naive DOCK8-deficient CD4
1 T cells can differentiate into effector cells producing T H 1 and T H 2, but not T H 17, cytokines in vitro
To determine whether defects in cytokine production by DOCK8-deficient memory CD4
1 T cells are cell intrinsic or due to extrinsic factors, we isolated naive CD4 1 T cells from healthy donors and DOCK8-deficient patients and subjected them to in vitro culture under T H 0 and T H 1-, T H 2-, or T H 17-polarizing conditions. Interestingly, DOCK8-deficient naive CD4
1 T cells differentiated into T H 1 cells (IFN-g and TNF-a) to the same extent as normal naive CD4 1 T cells (Fig 4, A, left  panel) . Consistent with the data for memory CD4 1 T cells ex vivo, DOCK8-deficient naive CD4
1 T cells produced significantly greater amounts of the T H 2 cytokine IL-13 than control naive CD4 1 T cells under T H 2-polarizing conditions (3-fold increase; Fig 4, A, middle panels). We also analyzed T H 2 differentiation by assessing cytokine expression in naive CD4
1 T cells by means of intracellular staining and flow cytometry after in vitro T H 2 polarization. This confirmed a preferential differentiation of DOCK8-deficient cells toward a T H 2 fate, with increased proportions of DOCK8-deficient naive CD4
1 T cells expressing IL-4 (9.9% DOCK8-deficient vs 5.5% control CD4
1 T cells) and IL-13 (5.9% DOCK8-deficient vs 1.7% control CD4
1 T cells). Together, these data provide evidence of a predominant intrinsic bias of DOCK8-deficient naive CD4
1 T cells differentiating toward a T H 2 effector fate. DOCK8-deficient naive CD4
1 T cells did not differentiate into IL-17A-and IL-17F-secreting cells when subjected to T H 17-polarizing conditions in vitro (Fig 4, A, right panels) . Notably, DOCK8-deficient naive CD4
1 T cells responded to the T H 17 culture, as shown by reductions in basal levels of IL-5 and IL-13 secretion compared with the T H 0 culture (data not shown).
When we examined memory CD4 1 T cells from healthy donors, production of IFN-g and IL-17A/F could be increased approximately 2-to 4-fold by T H 1 and T H 17 culture conditions, respectively, compared with T H 0 conditions (Fig 4, B) . The net increase in production of these cytokines by DOCK8-deficient memory CD4 1 T cells under T H 1 and T H 17 conditions compared with T H 0 conditions was also approximately 2-to 6-fold. Despite this, levels of IFN-g and IL-17A/F secreted by T H 1-and T H 17-stimulated DOCK8-deficient memory CD4 1 T cells were substantially less than not only those secreted by T H 1-and T H 17-stimulated normal memory CD4
1 T cells but also T H 0-stimulated normal memory CD4 1 T cells (Fig 4,  B) . This likely reflects expansion of the few T H 1 and T H 17 cells present in the DOCK8 memory CD4
1 T-cell compartment rather than de novo differentiation into these effector subsets in vitro.
Consistent with the data for cytokine secretion, DOCK8-deficient naive CD4
1 T cells that were polarized toward T H 1 and T H 2 fates upregulated T-bet (Fig 4, C) and GATA-3 (Fig 4,  D) , respectively, to the same extent as normal naive CD4 1 T cells. In our hands detection of RORgt expression by using flow cytometry was not particularly sensitive because we found that only a small proportion of naive CD4
1 T cells (approximately 5%) expressed RORgt in T H 17-compared with T H 0-activated cultures. 40 To overcome this, RORC expression was determined by using quantitative PCR. RORC was not expressed by naive CD4
1 T cells activated under T H 0 conditions but was upregulated in normal and DOCK8-deficient naive CD4 1 T cells cultured under T H 17-polarizing conditions (Fig 4, E) . Taken together, these data indicate the T H 17 cytokine defect in patients with DOCK8 deficiency is T cell intrinsic and cannot be restored by T H 17-polarizing conditions for either naive or memory cells. Furthermore, the ability of T H 17 culture conditions to induce RORC in the absence of DOCK8 indicates the defect in T H 17 differentiation is downstream of RORC. In contrast, DOCK8-deficient naive CD4
1 T cells differentiate normally into T H 1 cells and exhibit exaggerated T H 2 differentiation when provided with the appropriate stimuli in vitro.
Preferential production of T H 2 cytokines by DOCK8-deficient CD4 1 T cells correlates with reduced TCR-mediated activation
The strength of signal provided to CD4 1 T cells through the TCR greatly influences their differentiation to cytokineproducing effector cells. For instance, reduced signal strength favors T H 2 cells, [41] [42] [43] [44] whereas differentiation to T H 17 cells requires stronger or sustained TCR signaling. 45, 46 Our findings of heightened production of T H 2 cytokines by DOCK8-deficient naive and memory CD4
1 T cells led us to hypothesize that mutations in DOCK8 compromised TCR signal strength. To assess this, we cultured DOCK8-deficient CD4 1 T cells with differing doses of anti-CD2/CD3/CD28 beads for 3 days and then measured levels of expression of the activation molecules ICOS, CD25, CD69, and CD95. The rationale here is that decreasing the dose of the beads results in a qualitatively weaker signal. Although CD4 1 T cells from healthy control subjects exhibited heightened expression of ICOS, CD69, and CD25 at the 2 different doses of anti-CD2/CD3/CD28 beads tested, T cells was severely blunted (Fig 4, F) . Thus mutations in DOCK8 compromise T-cell activation by reducing the strength of signal delivered through the TCR and costimulatory receptor signaling pathways. In the case of T-cell differentiation, this results in skewing of the cells toward a T H 2 phenotype.
Specific sensitization of DOCK8-deficient patients to food allergens
Exaggerated T H 2 immune responses have traditionally been associated with allergy and atopic disease. 47 Thus it was intriguing to note that CD4 1 T cells from DOCK8-deficient patients were biased toward production of T H 2 cytokines and that these patients have severe allergies. To determine whether the T H 2 bias in DOCK8-deficient human CD4
1 T cells is related to their increased susceptibility to food allergies, we examined the specificity of IgE in serum samples from DOCK8-deficient patients and normal healthy donors to staple foods (ie, egg white, milk, codfish, wheat, peanut, and soybean), as well as to nonfood allergens, such as house dust mites. We found that a comparable frequency of healthy subjects and DOCK8-deficient patients had IgE specific to house dust mites (Fig 5, A) . Strikingly, the majority of plasma samples from DOCK8-deficient patients (80% [12/15] ) but none of the healthy control subjects tested had IgE that was specific for the staple food mix (Fig 5, B) . Thus DOCK8-deficient patients have a T H 2 bias that manifests clinically as specific sensitization to oral allergens, and this might explain the marked propensity of these immunodeficient patients to have food allergies.
DISCUSSION
Identifying defects in lymphocyte development or function in patients with primary immunodeficiencies (PIDs) provides the opportunity to elucidate the cellular and molecular basis for the clinical features of the disease. Indeed, studies of DOCK8-deficient human subjects and mice have revealed critical cell-intrinsic roles for DOCK8 in generating B-cell memory and long-lived humoral immunity, 5,48 CD8 1 T-cell differentiation and antiviral responses, 22, 23, 49, 50 NK cell cytotoxicity, 24 and NKT cell development. 25 Collectively, these defects underlie poor antibody responses to specific antigens and impaired cell-mediated immunity to pathogens, including HSV, HPV, and M contagiosum virus. We have now investigated CD4 1 T-cell differentiation in DOCK8-deficient patients to understand other aspects of AR-HIES, such as susceptibility to bacterial and fungal infections, atopic disease, food allergies, and hyper-IgE syndrome.
Our data revealed that DOCK8-deficient CD4 1 T cells have dysregulated expression of surface molecules, including CD27, CD57, CD95, and PD-1. This likely results from chronic infection with pathogens, such as herpes viruses (HSV, cytomegalovirus, and varicella-zoster virus), HPV, and M contagiosum virus, akin to what has been described for CD8
1 T cells in not only DOCK8 deficiency 22 but also other PIDs, such as X-liked lymphoproliferative disease, 51, 52 STAT3 deficiency, 53 and individuals with PIK3CD gain-of-function mutations, 54 which are characterized by chronic exposure to infectious pathogens. In the absence of DOCK8, memory CD4
1 T cells are polarized to a T H 2 cytokine phenotype at the expense of T H 1 and T H 17 cytokines. The reduction in T H 17 cell numbers was apparent not only from the lack of cells producing IL-17A, IL-17F, and IL-22 but also the reduction in numbers of CCR6 1 memory CD4 (Fig 4, C) and GATA-3 (Fig 4, D) was determined by means of flow cytometry; data represent the fold change (mean 6 SEM) in expression of the indicated transcription factor relative to T H 0 culture of the healthy control subject. E, expression of RORC was determined by using quantitative PCR. Data represent means and SEMs of 2 to 3 healthy donors and DOCK8-deficient patients. F, Memory CD4 1 T cells from healthy donors or DOCK8-deficient patients (n 5 2) were cultured with TAE beads at a cell/bead ratio of 2:1 and 0.5:1, and expression of ICOS, CD25, CD69, and CD95 was determined before culture (day 0) and 3 days after activation. Values represent means 6 SEMs of the mean fluorescence intensity (MFI) of each of the indicated surface receptors. Statistics were performed with Prism software by using 2-way ANOVA. *P < .05 and **P < .01.
=
J ALLERGY CLIN IMMUNOL VOLUME 139, NUMBER 3 suboptimal priming by antigen-presenting cells and provision of IL-12 in vivo. Consistent with this, DOCK8-deficient murine dendritic cells did not accumulate in the lymph node parenchyma, where they are required for T-cell priming during immune responses. 55 This defect was attributed to compromised Cdc42 function in the absence of DOCK8. 55 Another possibility is that excessive production of IL-4, which restrains differentiation of human CD4 1 T cells into T H 1 cells, 56 impairs IFN-g production by DOCK8-deficient memory CD4
1 T cells. This is consistent with our recent observations of heightened production of T H 2 cytokines and corresponding reductions in IFN-g production ex vivo by memory CD4
1 T cells from subjects with loss-offunction mutations in STAT3, IL21R, IL12RB1, TYK2, or RORC.
20,57 Although DOCK8-deficient naive CD4 1 T cells could express RORC in vitro after activation under T H 17-polarizing conditions, IL-17A/F cytokine secretion remained greatly impaired. Thus an intrinsic defect distal to inducing RORC expression underlies the inability of DOCK8-deficient CD4
1 T cells to become T H 17 cells. Although T H 1-and T H 17-polarizing conditions increased IFN-g and IL-17A/F production by DOCK8-deficient memory CD4
1 T cells, these cells produced lower levels of these cytokines than normal cells under similar culture conditions. Interestingly, CD4
1 T cells from DOCK8-deficient mice expressed normal levels of T-bet and GATA-3 when activated under T H 1-and T H 2-polarizing conditions, respectively, in vitro. 49 Interestingly, although IFN-g expression by in vitro-derived murine DOCK8-deficient T H 1 cells was normal, T H 2-polarized DOCK8-deficient CD4
1 T cells showed increases in IL-4-expressing cell numbers, 4 suggesting that murine DOCK8-deficient CD4 1 T cells also display a T H 2 bias.
These findings provide potential explanations for some of the clinical features of DOCK8 deficiency. First, lack of T H 17 cells would predispose DOCK8-deficient patients to infections with Candida albicans. This is akin to other monogenic PIDs characterized by impaired T H 17/IL-17-mediated immunity and the high incidence in CMCs in affected subjects (ie, loss-offunction mutations in STAT3, IL17RA, IL17RC, IL17F, ACT1, and RORC and gain-of-function mutations in STAT1). 20, 28, [57] [58] [59] [60] [61] [62] Compared with other PIDs with defects in T H 17 cytokines, IL-17A/IL-17F production by DOCK8-deficient memory CD4 1 T cells was less impaired than that observed for RORC-or STAT3-deficient memory CD4
1 T cells. 20, 57 Remarkably, the quantitative effect of specific gene mutations on generating T H 17 cells correlates with or predicts the incidence of fungal infections in these subjects. Thus approximately 85% of patients with mutations in STAT3 or RORC have CMC, 57, 63 but fungal infections are observed in only approximately 40% to 60% of DOCK8-deficient patients, as shown for the cohort studied here (Table I ) and in a larger study of 57 patients. 64 Thus there is likely a direct association between IL-17A/IL-17F production in patients with different PIDs and incidence of CMC.
Second, the predominance of memory CD4 1 T cells producing high levels of IL-4, IL-5, and IL-13 could contribute to the characteristic pathophysiologic T H 2 features of AR-HIES: severe allergy, eosinophilia, and hyper-IgE. 65 This exaggerated T H 2 response might also reduce T H 17 differentiation, 66 further compromising T H 17-mediated antifungal immune responses. Although memory CD4
1 T cells displayed reduced IFN-g production ex vivo, DOCK8-deficient naive CD4
1 T cells could differentiate into T H 1 cells in vitro. Thus T H 1-mediated immunity, although reduced, might be sufficient in these subjects to elicit protective immunity. Indeed, this is consistent with a lack of disease caused by poorly virulent mycobacteria, such as BCG vaccines and environmental species, which require IFNg-mediated immunity for protection, 67 in patients with DOCK8 deficiency. In the scenario of antiviral immunity, the increased T H 2 cytokine environment within the memory CD4 1 T-cell compartment might inhibit IFN-g production by CD8
1 T cells. Indeed, analysis of DOCK8-deficient memory CD8
1 T cells ex vivo revealed defective IFN-g expression and secretion compared with that seen in healthy donors (see Fig E2, A and B, in this article's Online Repository at www.jacionline.org). 1 Thus by diminishing T H 1 responses, a T H 2 bias could contribute to persistent viral infections in DOCK8-deficient patients.
Third, beyond T H 1, T H 2, and T H 17 cytokines, we also noted reduced production of IL-6 by DOCK8-deficient memory CD4 1 T cells. Although there have been no genetic studies linking impaired IL-6 production with infection with specific pathogens, autoantibodies against IL-6 were reported in a patient with recurrent staphylococcal infection. 68 Thus it is possible that poor IL-6-mediated immunity in patients with DOCK8 deficiency underlies staphylococcal infection in affected patients.
Fourth, although previous work demonstrated that DOCK8 functions intrinsically in B cells to regulate differentiation, reduced production of IL-21 (and potentially IL-10) by DOCK8-deficient memory CD4
1 T cells might also contribute to impaired humoral immune responses in patients with AR-HIES because these cytokines are the main drivers of human B-cell activation, proliferation, and differentiation. 69 This is supported by our observation that DOCK8-deficient memory CD4
1 T cells present with defects in IL-21 expression ex vivo (Fig 2) and naive DOCK8-deficient CD4 1 T cells did not differentiate into IL-211 cells as efficiently as normal naive CD4
1 T cells when cultured under T FH cell-polarizing conditions (see Fig E2, C) .
A characteristic and perhaps unique feature of DOCK8 deficiency compared with other PIDs (including those in which there are high levels of IgE, such as mutations in STAT3) is the very high incidence of food allergies. [1] [2] [3] [4] [5] The allergen-specific IgE from DOCK8-deficient patients was directed mostly toward staple foods rather than nonfood allergens, such as house dust mites. This is consistent with a recent report that showed that this pattern of allergen-specific IgE is unique to DOCK8 deficiency, 70 inasmuch that DOCK8-deficient patients had IgE directed toward food antigens, whereas patients with atopic dermatitis have IgE specific for aeroallergens, yet the reactivity of IgE in STAT3-deficient subjects against specific allergens was comparable with that seen in healthy donors. 70 Because food allergies are more common in children, who often outgrow them once they reach adolescence, IgE sensitization to food antigens and not house dust mites in patients with DOCK8 deficiency could be attributable to the younger age of our DOCK8 cohort compared with our healthy control subjects. However, this is unlikely because 9 of the 12 DOCK8-deficient patients who still had IgE specific to food antigens were adolescents or adults. In the scenario of STAT3 deficiency, the reduced level of IgE specific for food allergens when compared with that seen in patients with atopic dermatitis has been attributed to a defect in basophil activation and mast cell degranulation, with the latter process found to be STAT3 dependent. 71 This is interesting because although patients with mutations in DOCK8 or STAT3 or patients with atopic dermatitis all display increased serum IgE levels, eczema, and atopic disease, DOCK8 deficiency specifically predisposes to food allergies. The mechanism whereby this occurs is unclear, but it is tempting to speculate that it is related to the T H 2 bias of DOCK8-deficient memory CD4 1 T cells. Although T H 2 skewing has been reported in DOCK8-deficient mice in vitro, 49 to our knowledge, IgE responses after exposure to food allergens have not been investigated in mice but might provide invaluable insights into whether exposure to food allergens is the driver of IgE production in DOCK8 deficiency. Nevertheless, our findings reinforce the value of direct interrogation of patients' cells and highlight the need to be cognizant of species-specific differences that affect translation of murine studies to human subjects.
The underlying cause for the biased T H 2 nature of memory CD4
1 T cells in DOCK8-deficient patients remains to be determined. Examination of the TCR Vb repertoire in the CD4 1 T-cell compartment of DOCK8-deficient patients and healthy donors did not reveal any substantial differences (data not shown). However, there is evidence showing that the strength of the signal received through the TCR greatly influences differentiation of CD4 1 T cells. Specifically, low doses of antigen/low-level TCR signaling favor humoral or IL-4-mediated T H 2 immune responses, whereas high doses of antigen/strong TCR signaling favor cellular or IFN-g-mediated T H 1 immune responses. [41] [42] [43] This is also supported genetically because murine CD4
1 T cells with a hypomorphic Card11 mutation reduce TCR-mediated signal strength, resulting in exaggerated T H 2 differentiation, allergic disease, dermatitis, and hyper-IgE. 44 Based on this, we hypothesize that DOCK8-deficient CD4 1 T cells receive a qualitatively weaker TCR signal, potentially because of defective immunologic synapse formation, 48 which favors their preferential differentiation into T H 2 cells at the expense of other T H cell subsets. Our data demonstrating reduced induction of expression of activation markers on DOCK8-deficient CD4 1 T cells in response to increasing doses of anti-CD2/CD3/CD28 bead stimulation supports this hypothesis.
The original studies on the strength of TCR signals influencing murine T H cell differentiation predated the discovery of T H 17 cells. However, studies in mice and human subjects have since demonstrated a requirement for sustained TCR signaling in naive T cells for commitment to a T H 17 phenotype in vitro and in vivo. 45, 46 Thus we would predict that reduced TCR signal strength in DOCK8-deficient CD4
1 T cells impairs their differentiation into T H 17 cells.
In conclusion, we reveal that the CD4 1 T-cell compartment is greatly altered in the absence of DOCK8. Specifically, DOCK8-deficient patients have increased T H 2 cells and defects in T H 1 and T H 17 cell differentiation. This skewing of CD4 1 T-cell subsets likely accounts for some of the clinical manifestations in DOCK8-deficient patients. Strikingly, within our DOCK8 cohort, all the patients investigated had IgE specific for at least 1 of the food allergens (egg white, milk, codfish, wheat, peanut, and soybean) but not for nonfood allergens. These results indicate that the detection of high titers of IgE specific for food but not other allergens is predictive of DOCK8 deficiency. Thus future studies to identify signaling pathways and cellular processes affected by DOCK8 deficiency in CD4
1 T cells will not only improve our understanding of disease pathogenesis in affected DOCK8-deficient patients but also that in patients with atopic disease.
